LUNG CANCER RESEARCH FOUNDATION: Form 990, tax year 2023

View the entire original 990 at ProPublica ↗

Organization
LUNG CANCER RESEARCH FOUNDATION (EIN 14-1935776)
Tax period
2023-01-01 to 2023-12-31
Filed
2024-11-12
IRS object ID
202423179349306652
Schema version
2023v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2024-11-12T14:09:01-06:00ReturnTs
Tax Period End2023-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN872525370PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CITRIN COOPERMAN ADVISORS LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line150 ROCKEFELLER PLAZAAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10020ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2023-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN141935776EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1LUNG CANCER RESEARCH FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlLUNGBusinessNameControlTxt
Phone2125881580PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1501 7TH AVENUE 230AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10018ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonAUBREY RHODESPersonNm
Person TitleEXECUTIVE DIRECTORPersonTitleTxt
Phone2125881580PhoneNum
Signature2024-11-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonAMANDA ADAMSPreparerPersonNm
PTINP00748038PTIN
Phone2126971000PhoneNum
Preparation2024-11-11PreparationDt
FieldValueIRS element (for citing)
Tax2023TaxYr
Build TS2024-10-15 13:58:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerAUBREY RHODESPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1501 7TH AVENUE 230AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10018ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$6,773,322GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.LCRF.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2005FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionTHE MISSION OF THE LUNG CANCER RESEARCH FOUNDATION IS TO IMPROVE LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.ActivityOrMissionDesc
Voting Members Governing Body14VotingMembersGoverningBodyCnt
Voting Members Independent14VotingMembersIndependentCnt
Total Employee21TotalEmployeeCnt
Total Volunteers97TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$7,013,446PYContributionsGrantsAmt
CY Contributions Grants$6,148,851CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$28,829PYInvestmentIncomeAmt
CY Investment Income$212,398CYInvestmentIncomeAmt
PY Other Revenue-$438,719PYOtherRevenueAmt
CY Other Revenue$25,923CYOtherRevenueAmt
PY Total Revenue$6,603,556PYTotalRevenueAmt
CY Total Revenue$6,387,172CYTotalRevenueAmt
PY Grants And Similar Paid$3,052,308PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$2,481,669CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$2,157,339PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$2,473,909CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$127,467PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$759,132CYTotalFundraisingExpenseAmt
PY Other Expenses$1,219,816PYOtherExpensesAmt
CY Other Expenses$1,467,868CYOtherExpensesAmt
PY Total Expenses$6,556,930PYTotalExpensesAmt
CY Total Expenses$6,423,446CYTotalExpensesAmt
PY Revenues Less Expenses$46,626PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$36,274CYRevenuesLessExpensesAmt
Total Assets BOY$5,557,342TotalAssetsBOYAmt
Total Assets EOY$6,946,397TotalAssetsEOYAmt
Total Liabilities BOY$1,973,122TotalLiabilitiesBOYAmt
Total Liabilities EOY$3,310,501TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$3,584,220NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$3,635,896NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE MISSION OF THE LUNG CANCER RESEARCH FOUNDATION IS TO IMPROVE LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$3,429,071ExpenseAmt
Grant$2,481,669GrantAmt
DescRESEARCH: EACH YEAR, LCRF AWARDS RESEARCH GRANTS TO RECIPIENTS AROUND THE WORLD THAT DEMONSTRATE PROMISE AND INGENUITY IN THEIR WORK. INVESTIGATORS ARE SELECTED FROM HUNDREDS OF APPLICANTS AND REPRESENT SOME OF THE BRIGHTEST MINDS COMMITTED TO IMPROVING OUTCOMES FOR LUNG CANCER PATIENTS. THEY COME FROM VARIOUS CAREER PATHS INCLUDING SCIENTISTS, PHYSICIANS, STUDENTS, AND FELLOWS, AND WORKING ON A VARIETY OF INNOVATIVE RESEARCH PROJECTS RELATED TO LUNG CANCER RESEARCH.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,911,609ExpenseAmt
DescPATIENT EDUCATION & OUTREACH: WE PROVIDE UP-TO-DATE AND CREDIBLE SOURCES OF INFORMATION ON DIAGNOSIS, TREATMENT, AND WHAT TO EXPECT FROM TREATMENT THROUGH OUR FREE EDUCATIONAL MATERIALS. WE ALSO HAVE TOOLS TO HELP YOU FACILITATE DISCUSSIONS WITH YOUR HEALTHCARE TEAM SO YOU CAN PLAY AN ACTIVE ROLE IN TREATMENT DECISIONS. OUR MATERIALS ARE AVAILABLE IN BOTH DIGITAL DOWNLOAD AND PRINT FORMAT.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$5,340,680TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document22IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee21EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members14GoverningBodyVotingMembersCnt
Independent Voting Member14IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonKELLY BULLOCKPersonNm
Phone2125881580PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1501 7TH AVE SUITE 230AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10018ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (21 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
REINA HONTS
CHAIR/VICE CHIAR5.00Yes (X)Yes (X)$0$0$0
BRENDON M STILES MD
VICE CHAIR3.00Yes (X)Yes (X)$0$0$0
MARY ANN TIGHE
VICE CHAIR3.00Yes (X)Yes (X)$0$0$0
AARON M TIGHE
TREASURER3.00Yes (X)Yes (X)$0$0$0
KATERINA POLITI PHD
DIRECTOR1.00Yes (X)$0$0$0
JOAN H SCHILLER MD
DIRECTOR1.00Yes (X)$0$0$0
RAY E CHALME
DIRECTOR1.00Yes (X)$0$0$0
BRUCE DUNBAR
SECRETARY1.00Yes (X)Yes (X)$0$0$0
PETER FRY
DIRECTOR1.00Yes (X)$0$0$0
JILL FURMAN
DIRECTOR1.00Yes (X)$0$0$0
SCOTT MORRIS
DIRECTOR1.00Yes (X)$0$0$0
MATTHEW CIPRIANI
DIRECTOR1.00Yes (X)$0$0$0
ROSE ANN WEINSTEIN
DIRECTOR1.00Yes (X)$0$0$0
COLEEN CONNOR-ZIEGLER
CHAIR1.00Yes (X)Yes (X)$0$0$0
DENNIS CHILLEMI
EXECUTIVE DIRECTOR40.00Yes (X)$145,246$0$5,570
TONEL RODGERS
DIRECTOR, FINANCE & ADMINISTRATION40.00Yes (X)$127,063$0$17,462
ANTOINETTE WOZNIAK
CHIEF SCIENTIFIC OFFICER40.00$194,635$0$28,354Yes (X)
AUBREY RHODES
SENIOR VP, STRATEGY40.00$182,764$0$18,206Yes (X)
SHEILA SULLIVAN
SR. DIRECTOR, MARKETING & COMMUNICATION40.00$133,277$0$32,049Yes (X)
STACEY BOWERS
SR. DIRECTOR, COMMUNITY EN40.00$130,973$0$40,836Yes (X)
NATALIE REILLY-FINCH
SR. DIRECTOR OF DONOR DEVELOPMENT40.00$135,000$0$3,738Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,048,958TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$146,215TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K7IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CONRAD & ASSOCIATES LLCBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line111105 TARA RDAddressLine1Txt
CityPOTOMACCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20854ZIPCd
FieldValueIRS element (for citing)
ServicesMARKETINGServicesDesc
Compensation$155,000CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
Fundraising$1,853,459FundraisingAmt
All Other Contributions$4,295,392AllOtherContributionsAmt
Total Contributions$6,148,851TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$212,398TotalRevenueColumnAmt
Exclusion$212,398ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$412,073FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,853,459ContriRptFundraisingEventAmt
Fundraising Direct Expenses$386,150FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$25,923TotalRevenueColumnAmt
Exclusion$25,923ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$6,387,172TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$238,321ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$2,481,669TotalAmt
Program Services$2,481,669ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$506,572TotalAmt
Program Services$402,484ProgramServicesAmt
Management And General$30,163ManagementAndGeneralAmt
Fundraising$73,925FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,460,768TotalAmt
Program Services$1,078,683ProgramServicesAmt
Management And General$163,722ManagementAndGeneralAmt
Fundraising$218,363FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$20,362TotalAmt
Program Services$10,057ProgramServicesAmt
Management And General$4,531ManagementAndGeneralAmt
Fundraising$5,774FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$331,076TotalAmt
Program Services$247,857ProgramServicesAmt
Management And General$33,462ManagementAndGeneralAmt
Fundraising$49,757FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$155,131TotalAmt
Program Services$116,348ProgramServicesAmt
Management And General$15,513ManagementAndGeneralAmt
Fundraising$23,270FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$108,301TotalAmt
Program Services$100,947ProgramServicesAmt
Management And General$7,354ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$46,020TotalAmt
Program Services$17,501ProgramServicesAmt
Management And General$19,770ManagementAndGeneralAmt
Fundraising$8,749FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$214,167TotalAmt
Program Services$193,467ProgramServicesAmt
Management And General$8,280ManagementAndGeneralAmt
Fundraising$12,420FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$196,216TotalAmt
Program Services$196,216ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$179,553TotalAmt
Program Services$155,641ProgramServicesAmt
Management And General$1,430ManagementAndGeneralAmt
Fundraising$22,482FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$219,303TotalAmt
Program Services$164,477ProgramServicesAmt
Management And General$21,931ManagementAndGeneralAmt
Fundraising$32,895FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$75,839TotalAmt
Program Services$56,880ProgramServicesAmt
Management And General$7,584ManagementAndGeneralAmt
Fundraising$11,375FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$69,321TotalAmt
Program Services$65,854ProgramServicesAmt
Management And General$3,467ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$14,761TotalAmt
Program Services$14,023ProgramServicesAmt
Management And General$738ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$21,964TotalAmt
Program Services$16,473ProgramServicesAmt
Management And General$2,196ManagementAndGeneralAmt
Fundraising$3,295FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtFundraisingFundraisingAmtManagement And GeneralManagementAndGeneralAmtProgram ServicesProgramServicesAmt
BAD DEBTS$202,023$202,023
BANK FEES$85,672$82,179$3,493
PROGRAM MATERIALS$22,103$22,103
STATE FILING FEES$12,625$12,625

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$6,423,446TotalAmt
Program Services$5,340,680ProgramServicesAmt
Management And General$323,634ManagementAndGeneralAmt
Fundraising$759,132FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$33,893TotalAmt
Program Services$13,557ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$20,336FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$357,492BOYAmt
EOY$669,589EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$3,426,938BOYAmt
EOY$5,298,125EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,506,082BOYAmt
EOY$732,857EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
EOY$600EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$121,571BOYAmt
EOY$140,415EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$55,000LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$55,000LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$145,259BOYAmt
EOY$104,811EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,557,342BOYAmt
EOY$6,946,397EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$242,499BOYAmt
EOY$419,291EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$1,567,602BOYAmt
EOY$2,423,603EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$32,735BOYAmt
EOY$401,269EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$130,286BOYAmt
EOY$66,338EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,973,122BOYAmt
EOY$3,310,501EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,427,004BOYAmt
EOY$1,662,625EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$1,157,216BOYAmt
EOY$1,973,271EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$3,584,220BOYAmt
EOY$3,635,896EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,557,342BOYAmt
EOY$6,946,397EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$36,274ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$87,950OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,916,763CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,465,693CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$6,344,359CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,013,446CurrentTaxYearMinus1YearAmt
Current Tax Year$6,148,851CurrentTaxYearAmt
Total$30,889,112TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,916,763CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,465,693CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$6,344,359CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,013,446CurrentTaxYearMinus1YearAmt
Current Tax Year$6,148,851CurrentTaxYearAmt
Total$30,889,112TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$5,557,884SubstantialContributorsTotAmt
Public Support Total170$25,331,228PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,178CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,357CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,402CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$28,829CurrentTaxYearMinus1YearAmt
Current Tax Year$212,398CurrentTaxYearAmt
Total$247,164TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year$25,923CurrentTaxYearAmt
Total$25,923TotalAmt
FieldValueIRS element (for citing)
Total Support$31,162,199TotalSupportAmt
Gross Receipts Rltd Activities$9,780GrossReceiptsRltdActivitiesAmt
Public Support CY1700.81290PublicSupportCY170Pct
Public Support PY1700.84950PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$55,000OtherCostOrOtherBasisAmt
Depreciation$55,000DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$0TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescOPERATING LEASE LIABILITIESDesc
Amt$66,338Amt
FieldValueIRS element (for citing)
Total Liability$66,338TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$6,400,790TotalRevEtcAuditedFinclStmtAmt
Donated Services And Use Fclts$13,618DonatedServicesAndUseFcltsAmt
Revenue Not Reported$13,618RevenueNotReportedAmt
Revenue Subtotal$6,387,172RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$6,387,172TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$6,349,114TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$13,618DonatedServicesUseFcltsAmt
Expenses Not Reported$13,618ExpensesNotReportedAmt
Expenses Subtotal$6,335,496ExpensesSubtotalAmt
Other Expenses Not Included$87,950OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$87,950ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$6,423,446TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART X, LINE 2:THE FOUNDATION RECOGNIZES AND MEASURES ITS UNRECOGNIZED TAX BENEFITS IN ACCORDANCE WITH FASB ASC 740, INCOME TAXES. UNDER THAT GUIDANCE, THE FOUNDATION ASSESSES THE LIKELIHOOD, BASED ON THEIR TECHNICAL MERIT, THAT TAX POSITIONS WILL BE SUSTAINED UPON EXAMINATION BASED ON THE FACTS, CIRCUMSTANCES AND INFORMATION AVAILABLE AT THE END OF EACH PERIOD. THE MEASUREMENT OF UNRECOGNIZED TAX BENEFITS IS ADJUSTED WHEN NEW INFORMATION IS AVAILABLE, OR WHEN AN EVENT OCCURS THAT REQUIRES A CHANGE. MANAGEMENT HAS EVALUATED THE FOUNDATION'S TAX POSITIONS AND BELIEVES THAT THE FOUNDATION HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE ADJUSTMENTS TO THE FINANCIAL STATEMENTS.
PART XII, LINE 4B - OTHER ADJUSTMENTS:RETURNED GRANT FUNDS NETTED AGAINST EXPENSE 87,950.

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1ELLIOT'S LEGACYEvent1Nm
Gross Receipts Event1$446,420GrossReceiptsEvent1Amt
Charitable Contri Event1$446,420CharitableContriEvent1Amt
Rent Facility Costs Event1$2,880RentFacilityCostsEvent1Amt
Other Direct Expenses Event1$124,759OtherDirectExpensesEvent1Amt
Event2GALAEvent2Nm
Gross Receipts Event2$565,338GrossReceiptsEvent2Amt
Charitable Contri Event2$392,338CharitableContriEvent2Amt
Gross Revenue Event2$173,000GrossRevenueEvent2Amt
Rent Facility Costs Event2$77,264RentFacilityCostsEvent2Amt
Other Direct Expenses Event2$46,528OtherDirectExpensesEvent2Amt
Other Events Total10OtherEventsTotalCnt
Gross Receipts Other Events$1,253,774GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$1,014,701CharitableContriOtherEventsAmt
Gross Revenue Other Events$239,073GrossRevenueOtherEventsAmt
Rent Fclty Costs Other Events$1,268RentFcltyCostsOtherEventsAmt
Oth Direct Expnss Other Events$133,451OthDirectExpnssOtherEventsAmt
Gross Receipts Total$2,265,532GrossReceiptsTotalAmt
Charitable Contributions Tot$1,853,459CharitableContributionsTotAmt
Gross Revenue Total Events$412,073GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$81,412RentFcltyCostsTotalEventsAmt
Oth Direct Expnss Total Events$304,738OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$386,150DirectExpenseSummaryEventsAmt
Net Income Summary$25,923NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (24 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZAHOUSTONTX77030741613878501(C)(3)$12,810$0RESEARCH
DANA-FARBER CANCER INSTITUTE INC
450 BROOKLINE AVENUE BP418BOSTONMA02215042263040501(C)(3)$10,675$0RESEARCH
DARTMOUTH-HITCHCOCK CLINICAL TRIALS
ONE MEDICAL CENTER DRIVELEBANONNH03756222519596501(C)(3)$10,675$0RESEARCH
DUKE UNIVERSITY
PO BOX 104132DURHAMNC27708560532129501(C)(3)$149,923$0RESEARCH
H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC
PO BOX 406249ATLANTAGA30384593238634501(C)(3)$10,675$0RESEARCH
LOYOLA UNIVERSITY OF CHICAGO
820 N MICHIGAN AVECHICAGOIL60611361408475501(C)(3)$268,973$0RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA02114042697983501(C)(3)$160,675$0RESEARCH
MAYO CLINIC
200 FIRST STREET SWROCHESTERME55905416011702501(C)(3)$150,000$0RESEARCH
MD ANDERSON CANCER CENTER
1515 HOLCOMBE BOULEVARDHOUSTONTX77030746001118501(C)(3)$504,106$0RESEARCH
MEDICAL UNIVERSITY OF SOUTH CAROLINA
1 SOUTH PARK CIRCLE BUILDING 1 STECHARLESTONSC29407576000722501(C)(3)$10,675$0RESEARCH402 CHARLESTON
MEMORIAL SLOAN KETTERING CANCER CENTER
1275 YORK AVENUENEW YORKNY10065131924236501(C)(3)$176,000$0RESEARCH
NORTHWESTERN UNIVERSITY
633 CLARK STREETEVANSTONIL60208362167817501(C)(3)$10,675$0RESEARCH
REGENTS OF UNIVERSITY OF MICHIGAN
5082 WOLVERINE TOWER 3003 SOUTHANN ARBORMI48109386006309501(C)(3)$14,945$0RESEARCHSTATE STREET
THE BRIGHAM & WOMEN'S HOSPITAL INC
PO BOX 3149BOSTONMA02241042312909501(C)(3)$10,675$0RESEARCH
THE CURATORS OF THE UNIVERSITY OF MISSOURI
118 UNIVERSITY HALLCOLUMBIAMT65211436003859501(C)(3)$53,375$0RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
1855 FOLSOM STREET SUITE 425SAN FRANCISCOCA94143946036493501(C)(3)$150,000$0RESEARCH
THE UNIVERSITY OF ALABAMA
801 5TH AVE SOUTH ROOM 251BIRMINGHAMAL35233636005396501(C)(3)$269,222$0RESEARCH
TRUSTEES OF BOSTON UNIVERSITY
881 COMMONWEALTH AVENUEBOSTONMA02215042103547501(C)(3)$150,000$0RESEARCH
UC DAVIS COMPREHENSIVE CANCER CENTER
1 SHIELDS AVENUEDAVISCA95616946036494501(C)(3)$10,675$0RESEARCH
UCLA
10889 WILSHIRE BLVD SUITE 1100LOS ANGELESCA90024952250801501(C)(3)$40,565$0RESEARCH
VANDERBILT UNIVERSITY MEDICAL CENTER
DEPT 1236 PO BOX 121236DALLASTX75312352528741501(C)(3)$135,000$0RESEARCH
VIRGINIA CANCER SPECIALISTS PC
3040 WILLIAMS DRIVE SUITE 100FAIRFAXVA22031541795091501(C)(3)$10,675$0RESEARCH
WASHINGTON UNIVERSITY IN ST LOUIS
PO BOX 505505ST LOUISMT63150430653611501(C)(3)$10,675$0RESEARCH
YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTS PO BOXNEW HAVENCT06508060646973501(C)(3)$150,000$0RESEARCH1873
FieldValueIRS element (for citing)
Total501c3 Org27Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationAPPLICATIONS TO LCRF'S SCIENTIFIC GRANT PROGRAM ARE REVIEWED VIA A THREE-PART PROCESS. THEY ARE FIRST SCREENED BY LCRF STAFF TO ENSURE COMPLETENESS AND COMPLIANCE WITH ELIGIBILITY CRITERIA, BUDGET, AND OTHER SUBMISSION REQUIREMENTS. THE APPLICATIONS ARE NEXT SCREENED FOR SCIENTIFIC RATIONALE, CREATIVITY, APPROPRIATENESS OF TIMELINES AND BUDGET, INSTITUTIONAL LETTERS OF SUPPORT AND IMPACT ON THE FIELD OF LUNG CANCER RESEARCH BY THE LCRF SCIENTIFIC ADVISORY BOARD (SAB). NEXT, A SET OF SEMI-FINALISTS ARE INDEPENDENTLY AND COMPREHENSIVELY REVIEWED BY SUBCOMMITTEES OF THREE EXPERTS FROM THE SAB AND SCORED BY STANDARD NIH/NCI CRITERIA. UPON COMPLETION OF THE REVIEW PROCESS, APPLICATIONS ARE RANKED IN ORDER FROM HIGHEST TO LOWEST-SCORING, AND PROPOSALS SELECTED TO BE CONSIDERED FOR FUNDING ARE CHOSEN BASED STRICTLY ON THE APPLICATION SCORES - NO EXTERNAL REVIEW IS ALLOWED. CURRENTLY FUNDED PROJECTS ARE EVALUATED ON AN ANNUAL BASIS WITH AN ASSESSMENT OF A PROGRESS REPORT.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ANTOINETTE WOZNIAK
CHIEF SCIENTIFIC OFFICER$194,635$0$0$0$0$0$0$0$28,354$0$222,989$0$0$0
AUBREY RHODES
SENIOR VP, STRATEGY$182,764$0$0$0$0$0$7,448$0$10,758$0$200,970$0$0$0
STACEY BOWERS
SR. DIRECTOR, COMMUNITY EN$130,973$0$0$0$0$0$5,400$0$35,436$0$171,809$0$0$0
SHEILA SULLIVAN
SR. DIRECTOR, MARKETING & COMMUNICAT$133,277$0$0$0$0$0$5,427$0$26,622$0$165,326$0$0$0
DENNIS CHILLEMI
EXECUTIVE DIRECTOR$145,246$0$0$0$0$0$5,570$0$0$0$150,816$0$0$0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS:RESEARCH: DESPITE BEING THE LEADING CAUSE OF CANCER MORTALITY, LUNG CANCER RECEIVES FAR LESS RESEARCH FUNDING PER DEATH. LUNG CANCER RECEIVES $3,580 PER DEATH COMPARED TO BREAST CANCER AT $19,050, PROSTATE CANCER AT $8,116, AND PANCREATIC CANCER AT $4,796. THAT IS WHY FUNDING FROM NON-GOVERNMENTAL ORGANIZATIONS IS SO CRITICAL. THE LUNG CANCER RESEARCH FOUNDATION (LCRF) PLAYS A PIVOTAL ROLE IN THIS FUNDING LANDSCAPE. SINCE 2005, THE LUNG CANCER RESEARCH FOUNDATION, AND ITS PROGENITOR ORGANIZATIONS, HAS BEEN COMMITTED TO FUNDING CUTTING EDGE RESEARCH THAT TRANSFORMS THE LUNG CANCER TREATMENT LANDSCAPE. WHEN WE FIRST OPENED OUR DOORS, OUR MISSION WAS SIMPLE: PROVIDE HOPE BY FUNDING THE BEST RESEARCH AND HELP BRING IT TO PEOPLE. WE HAVE BEEN WILDLY SUCCESSFUL. IN 18 YEARS, WE HAVE BECOME ONE OF THE LARGEST PRIVATE FUNDERS OF LUNG CANCER RESEARCH ENABLING EARLIER DETECTION, DEEPER UNDERSTANDING OF THE MECHANISMS THAT ALLOW LUNG CANCER TO FORM, AND NEW AND EXPANDED TREATMENT OPTIONS THAT HAVE SAVED MANY LIVES. SIMULTANEOUSLY, OUR SCIENTIFIC ADVISORY BOARD HAS BECOME ONE OF THE PREEMINENT BODIES IN THE LUNG CANCER RESEARCH COMMUNITY. FURTHERMORE, OUR INVESTMENT IN EARLY CAREER INVESTIGATORS CONTINUES TO ALLOW NEW TALENT TO THRIVE AND GROW IN THE SPACE AS IS DEMONSTRATED THROUGH FOLLOW-ON FUNDING MANY HAVE RECEIVED SINCE RECEIVING THEIR LCRF GRANT. TO DATE, LCRF HAS PROVIDED 419 RESEARCH GRANTS TOTALING NEARLY $44 MILLION, THE LARGEST AMOUNT PROVIDED BY A NON-GOVERNMENTAL ORGANIZATION DEDICATED TO FUNDING LUNG CANCER RESEARCH. SUPPORT WITHIN THE PATIENT COMMUNITY, RESEARCHERS, STRATEGIC PARTNERS, AND INDUSTRY PARTNERS IS KEY TO OUR PRESENT SUCCESS AS WELL AS ACHIEVING OUR FUTURE VISION TO FIND A CURE FOR LUNG CANCER. DURING 2023, WE FUNDED TEN (10) RESEARCH GRANTS ACROSS FIVE (5) RESEARCH GRANT TRACKS. TWO (2) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRF LEADING EDGE RESEARCH GRANT PROGRAM WHICH FUNDS INNOVATIVE PROJECTS ACROSS THE FULL SPECTRUM OF BASIC, TRANSLATIONAL, CLINICAL, EPIDEMIOLOGICAL, HEALTH SERVICES, AND RESEARCH FOCUSED ON A MYRIAD OF TOPICS. THE PROJECTS WILL EXPLORE THE FOLLOWING: - INVESTIGATING NOVEL SYNTHETIC LETHAL VULNERABILITIES IN EGFR-DRIVEN LUNG CANCER - DEEP WHOLE GENOME SEQUENCING OF CIRCULATING TUMOR DNA FOR STUDYING EVOLUTION AND THERAPY RESISTANCE IN SMALL CELL LUNG CANCER TWO (2) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRF RESEARCH GRANT ON UNDERSTANDING RESISTANCE IN LUNG CANCER. THESE PROJECTS WILL FOCUS ON UNDERSTANDING THE DEVELOPMENT, PREVENTION, AND THERAPY OF RESISTANCE BY SUPPORTING PROJECTS THAT ARE IDENTIFYING, CHARACTERIZING, TREATING OR PREVENTING RESISTANCE TO THERAPIES IN LUNG TUMOR CELLS, TISSUES, MOUSE MODELS, AND/OR PATIENTS. THESE STUDIES WILL ENHANCE THE MOMENTUM OF IMPROVING LUNG CANCER OUTCOMES AND HAVE THE POTENTIAL TO INCREASE SURVIVORSHIP. THESE PROJECTS WILL EXPLORE THE FOLLOWING: - CHARACTERIZATION AND THERAPEUTIC TARGETING OF A TUMOR-TUMOR MICROENVIRONMENT NETWORK PROMOTING RESISTANCE TO TARGETED THERAPY IN LUNG CANCER - UNCOVERING NOVEL VULNERABILITIES TO TREAT SCLC THERAPY RESISTANCE TWO (2) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRF MINORITY CAREER DEVELOPMENT AWARD (CDA). MINORITY APPLICANTS ARE LESS LIKELY TO RECEIVE GRANTS, TO HAVE THE R PHASES OF K01 OR K99 AWARDS ACTIVATED, NEED MORE SUBMISSIONS TO OBTAIN FUNDING, AND OFTEN WILL NOT RESUBMIT PROPOSALS. AS MINORITY APPLICANTS MUST OVERCOME SYSTEMIC AND STRUCTURAL BARRIERS DUE TO RACE, ETHNICITY, COUNTRY OF ORIGIN, SOCIOECONOMIC STATUS, AND/OR LANGUAGE, MANY LEAVE ACADEMIA WHICH FURTHER EXACERBATES THE LACK OF DIVERSITY IN SCIENCE, TECHNOLOGY, ENGINEERING AND MATHEMATICS (STEM) AND MEDICAL FIELDS. TO PROVIDE PROTECTED TIME AND MENTORING TO THESE TRAINEES, WE CONTINUE TO OFFER THE LCRF MINORITY CAREER DEVELOPMENT AWARD (CDA) FOR LUNG CANCER FOR MINORITY POSTDOCTORAL/CLINICAL FELLOWS AND ASSISTANT PROFESSORS WITHIN 10 YEARS OF COMPLETING THEIR MD AND/OR PHD DEGREES TO SUBMIT PROPOSALS. THE PROJECTS WILL EXPLORE THE FOLLOWING: - HARNESSING B CELL SPECIFIC CHECKPOINT MOLECULES IN LUNG CANCER - IMPACT OF SENESCENT CELLS ON LUNG TUMORIGENESIS ONE (1) RESEARCH GRANT WAS FUNDED THROUGH THE LCRF RESEARCH GRANT ON EARLY DETECTION AND PRE-NEOPLASIA IN LUNG CANCER. GIVEN THE SIGNIFICANCE AND NEED FOR EARLY DETECTION OF LUNG CANCER AND ADVANCEMENTS IN MOLECULAR SCREENING, LCRF CONTINUES TO OFFER A FUNDING MECHANISM TO SUPPORT RESEARCH PROJECTS THAT FACILITATE OR ADVANCE THE UNDERSTANDING AND CHARACTERIZATION OF PRE-NEOPLASIA OR APPROACHES FOR EARLY DETECTION OF LUNG CANCER. WORK SUPPORTED THROUGH THIS MECHANISM ADDRESSES IMPORTANT QUESTIONS IN NON-SMALL CELL AND SMALL CELL LUNG CANCER. THE PROJECTS WILL EXPLORE THE FOLLOWING: - THE SPATIAL B CELL LANDSCAPE IN LUNG SQUAMOUS PREMALIGNANT LESION THREE (3) RESEARCH GRANTS WERE FUNDED THROUGH THE LCRF-DAIICHI SANKYO-ASTRAZENECA RESEARCH GRANT ON ANTIBODY DRUG CONJUGATES, SUPPORTING RESEARCH TO STUDY HER2 DIRECTED AND TROP2 DIRECTED ADCS INCLUDING MECHANISM OF ACTION, BIOMARKERS, AND RESISTANCE MECHANISMS. THE PROJECTS WILL EXPLORE THE FOLLOWING: - DECIPHERING THE ADC CODE: A PROTEOGENOMIC QUEST IN LUNG CANCER - PULMONARY HIGH-GRADE NEUROENDOCRINE CARCINOMAS AS INDICATIONS FOR ANTIBODY-DRUG CONJUGATES TARGETING TROP2 AND HER2 - LEVERAGING LIQUID BIOPSY TO IDENTIFY THE OPTIMAL CLINICAL NICHE FOR TROP2-TARGETING IN NSCLC IN ADDITION, THE FOUNDATION IS CURRENTLY ADMINISTRATING RESEARCH PARTNERSHIPS WITH THE LUNG CANCER MUTATION CONSORTIUM. LCRF'S PARTNERSHIP WITH THE LUNG CANCER MUTATION CONSORTIUM (LCMC) DATES BACK TO 2011 COVERING THREE CLINICAL TRIALS. THE LCMC2 CLINICAL TRIAL ENROLLED 1,000 PATIENTS VIA A NETWORK OF FOURTEEN (14) NOTABLE DOMESTIC CLINICAL RESEARCH SITES. THE CLINICAL TRIAL STUDIED THE IMPACT OF SMOKING AND TP53 MUTATIONS IN LUNG ADENOCARCINOMA PATIENTS WITH TARGETABLE MUTATIONS. THE LCMC3 CLINICAL TRIAL BEGAN IN 2017 AND HAS ENROLLED 1,000 PATIENTS VIA A NETWORK OF FIVE (5) DOMESTIC CLINICAL RESEARCH SITES. LCMC3 IS DESIGNED AS A NEOADJUVANT AND ADJUVANT TRIAL OF IMMUNE CHECKPOINT BLOCKADE FOR STAGE IB-IIIA NON-SMALL CELL LUNG CANCER. FINAL REPORTING FROM THIS CLINICAL TRIAL SHOULD BE COMPLETED IN LATE 2024. LAUNCHED IN LATE 2020, LCMC4 IS A STUDY WITH A GOAL OF ENLISTING 1,000 PATIENTS VIA A NETWORK OF 25+ DOMESTIC CLINICAL RESEARCH SITES. THE AIM OF THE CLINICAL TRIAL IS TO DETERMINE THE FEASIBILITY OF COMPREHENSIVE MOLECULAR PROFILING TO DETECT ACTIONABLE ONCOGENIC DRIVERS IN PATIENTS WITH SUSPECTED EARLY-STAGE LUNG CANCERS SCHEDULED TO UNDERGO BIOPSIES TO ESTABLISH THE DIAGNOSIS OF LUNG CANCER. SEVEN (7) GRANTS IN SUPPORT OF THE LCMC4 - LEADER NEOADJUVANT SCREENING TRIAL HAVE BEEN MADE. IN 2023, OUR RESEARCH INVESTMENT WAS FUNDED WITHOUT THE NEED FOR DEFICIT SPENDING, AND WE ARE POISED TO GROW OUR RESEARCH INVESTMENT IN THE COMING YEARS.
FORM 990, PART III LINE 4B, PROGRAM SERVICE ACCOMPLISHMENTS:PATIENT EDUCATION & OUTREACH: THE PATIENT EDUCATION PORTFOLIO INCLUDES PRINT AND DIGITAL EDUCATIONAL RESOURCES (PDF DOWNLOADABLE FORMAT AS WELL AS EASILY ACCESSIBLE WEBSITE CONTENT) THAT ARE PROVIDED AT NO COST. THE OVERALL GOALS OF OUR PATIENT EDUCATION MATERIALS ARE TO HELP PATIENTS AND THEIR FAMILIES BETTER UNDERSTAND LUNG CANCER, LEARN ABOUT TREATMENT OPTIONS, PARTICIPATE IN SHARED DECISION MAKING WITH THEIR CARE TEAM, MAKE DECISIONS ABOUT CLINICAL TRIALS, AND UNDERSTAND THE IMPLICATIONS OF COMPREHENSIVE BIOMARKER TESTING. PATIENTS AND CAREGIVERS NEED INFORMATION AT ALL STEPS IN THE CONTINUUM OF CARE, FROM DIAGNOSIS THROUGH TREATMENT AND BEYOND. THE LUNG CANCER RESEARCH FOUNDATION HAS A PORTFOLIO OF EDUCATIONAL RESOURCES TO HELP PATIENTS AND THEIR FAMILIES BETTER UNDERSTAND LUNG CANCER AND LEARN ABOUT THEIR TREATMENT OPTIONS. HELPING PATIENTS TO UNDERSTAND NEW TREATMENTS AND THE HOPE OFFERED BY THESE TREATMENT ADVANCES ARE KEY OBJECTIVES OF OUR EDUCATIONAL MATERIALS. WE ALSO HAVE MATERIALS DESIGNED TO EDUCATE THE PUBLIC ABOUT THE MAGNITUDE OF LUNG CANCER AS A HEALTH CARE PROBLEM AND WAYS TO IDENTIFY SYMPTOMS OF THE DISEASE. IN 2023, LCRF DISTRIBUTED OVER 184,000 EDUCATIONAL PIECES TO LUNG CANCER PATIENTS, CAREGIVERS, ADVOCATES AND HEALTHCARE PROFESSIONALS ACROSS THE NATION IN BOTH PRINT AND DIGITAL FORMAT. OUR WEBSITE ALSO CONTAINS LINKS TO INFORMATION AND RESOURCES, WHICH RECEIVES ON AVERAGE OF MORE THAN 200,000 PAGEVIEWS ANNUALLY. OUR CONTINUED GOAL IS TO STEADILY INCREASE OUR MATERIALS DISTRIBUTED, PARTICULARLY WITH DIGITAL DOWNLOADS AS THERE HAS BEEN A SURGE IN DEMAND FOR READILY AVAILABLE INFORMATION. THE KEY OBJECTIVES OF THE PORTFOLIO ARE TO: EMPOWER PATIENTS AND CAREGIVERS BY INCREASING THEIR KNOWLEDGE OF LUNG CANCER, BIOMARKER TESTING, CLINICAL TRIALS AND TREATMENT OPTIONS; PROVIDE AN UP-TO-DATE AND CREDIBLE SOURCE OF INFORMATION ON AVAILABLE TREATMENTS, EDUCATE PATIENTS ON WHAT TO EXPECT FROM TREATMENT AND WHAT IS CRITICAL FOR OPTIMAL OUTCOMES; PROVIDE TOOLS TO FACILITATE DISCUSSIONS BETWEEN PATIENTS AND HEALTHCARE PROVIDERS; EDUCATE THE PUBLIC ABOUT THE MAGNITUDE OF LUNG CANCER AS A HEALTH CARE ISSUE, WAYS TO IDENTIFY SYMPTOMS OF THE DISEASE, AND EXPLAIN THE IMPORTANCE OF EARLY DETECTION, TUMOR BIOMARKER TESTING AND CLINICAL TRIAL PARTICIPATION; SHARE PROGRESS AND IMPACT OF RESEARCH (INCLUDING THAT WHICH IS FUNDED BY LCRF), AND EXPLAIN WHY FUNDING RESEARCH IS CRUCIAL FOR THE DEVELOPMENT OF NEW TREATMENTS FOR LUNG CANCER; AND ENSURE THAT THE MATERIALS ARE CULTURALLY APPROPRIATE, AT APPROPRIATE LITERACY LEVELS, AND ACCESSIBLE THROUGH A VARIETY OF DELIVERY METHODS (ONLINE, THROUGH COMMUNITY GROUPS AND COMMUNITY HEALTHCARE PROVIDERS, PATIENT AND CAREGIVER FOCUSED EVENTS, ETC.). THE PATIENT EDUCATION MATERIALS ARE EVIDENCE-BASED AND DEVELOPED IN CONJUNCTION WITH THE EDUCATION AND ENGAGEMENT COMMITTEE, COMPOSED OF ONCOLOGISTS, RESEARCHERS, ONCOLOGY NURSES, SOCIAL WORKERS, AND PATIENTS/CAREGIVERS. THE PATIENT EDUCATIONAL PORTFOLIO IS ALSO CRAFTED WITH ASSISTANCE FROM THE FEEDBACK WE RECEIVE FROM OUR COMMUNITY. OUR MATERIALS ARE RATED ON AVERAGE A 4.6/5 ACCORDING TO THE FEEDBACK COLLECTED FROM INDIVIDUALS WHO DOWNLOAD OR ORDER OUR PRINT MATERIALS ON OUR WEBSITE. SAMPLE FEEDBACK INCLUDES: THANK YOU FOR PROVIDING FREE EDUCATIONAL RESOURCES. I AM A THORACIC NURSE NAVIGATOR AND PROVIDE THESE TO ALL OF MY LUNG CANCER PATIENTS. MY PATIENTS LIKE AND APPRECIATE THEM VERY MUCH. THANK YOU SO MUCH FOR PROVIDING INFORMATION TO PEOPLE TRYING TO NAVIGATE A LUNG CANCER DIAGNOSIS AND ALL THE STRESS RELATED TO THE ENTIRE PROCESS. MY MOTHER WAS RECENTLY DIAGNOSED WITH LUNG CANCER. VERY HEARTBREAKING AND A SURPRISE TO US ALL. HEARD NOTHING BUT GOOD REVIEWS ABOUT LCRF SO I LOOK FORWARD TO LEARNING ABOUT EVERYTHING AND I APPRECIATE WHAT YOU ALL DO. I LOVE THE UPDATED LIVING WITH LUNG CANCER BOOKLET. I READ IT FROM COVER TO COVER AND FEEL THAT IT WAS VERY NICELY DONE. IT IS DEFINITELY VERY COMPREHENSIVE IN THAT IT INCLUDES COPING WITH DIAGNOSIS/TREATMENT, INFORMATION ABOUT OUR NEWER TARGETED AND IMMUNOTHERAPIES, AND TREATMENT SIDE-EFFECT MANAGEMENT. GOOD JOB ON YOUR END! LUNG CANCER SUPPORT LINE: OUR LUNG CANCER SUPPORT LINE IS A TOLL-FREE NUMBER (844)-835-4325, AND IS AVAILABLE TO ANYONE AFFECTED BY LUNG CANCER, PRIMARILY LUNG CANCER PATIENTS AND CAREGIVERS. THE SUPPORT LINE OPERATES MONDAY-FRIDAY 9AM-5PM ET AND IS EQUIPPED WITH EXTENSIVE AND UP-TO-DATE RESOURCE GUIDES FOR COMMON NEEDS AND SERVICES FOR LUNG CANCER PATIENTS SUCH AS FINANCIAL ASSISTANCE, TRANSPORTATION OR LODGING TO/FROM MEDICAL APPOINTMENTS, SUPPORT GROUPS, AND MUCH MORE. LUNG CANCER PATIENTS AND THEIR CAREGIVERS MAY CALL OR EMAIL THE PROGRAM AS OFTEN AS THEY WISH, AND THE SERVICE IS OFFERED FREE OF CHARGE. THE LUNG CANCER SUPPORT LINE HELPS FILL AN UNMET NEED BY PROVIDING PERSONALIZED, ONE-ON-ONE SUPPORT TO CALLERS WHO ARE FACING THE CHALLENGES OF LUNG CANCER. IN 2023, WE HAD OVER 1,000 INQUIRIES COME IN THROUGH THE SUPPORT LINE. OVER HALF OF CALLERS ARE NEWLY DIAGNOSED PATIENTS OR CAREGIVERS OF THOSE WHO ARE RECENTLY DIAGNOSED, PROVING THAT THE SUPPORT LINE PROVIDES A TIMELY SERVICE FOR THOSE SEEKING SUPPORT. MANY SUPPORT LINE INQUIRIES ALSO COME IN FROM HEALTHCARE INSTITUTIONS OR COMMUNITY-BASED INSTITUTIONS LOOKING FOR RESOURCES FOR THEIR PATIENTS. OUR CONTINUED GOAL FOR THE SUPPORT LINE IS TO STRENGTHEN OUR COMMUNICATION WITH THOSE WHO ARE NEWLY DIAGNOSED AND ENGAGED IN OUR EDUCATIONAL PROGRAMS. WE ALSO HOPE TO INCREASE OUR SUPPORT LINE REACH BY 10% OVER THE NEXT YEAR VIA TARGETED OUTREACH AND PROMOTION OF OUR SERVICES. THROUGH THE SUPPORT LINE, WE: PROVIDE A QUALITY SERVICE TO PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS, BY OFFERING SUPPORT IN THEIR AREA OF NEED DURING ONE-ON-ONE INTERACTIONS; EMPOWER PATIENTS AND CAREGIVERS THROUGH CONNECTIONS TO RESOURCES (EDUCATION, ASSISTANCE, AND SUPPORT); ENHANCE PATIENTS AND CAREGIVERS' UNDERSTANDING OF LUNG CANCER; INCREASE NUMBER OF SUPPORT INQUIRIES AND TOTAL NUMBER OF INTERACTIONS BETWEEN LCRF SUPPORT SERVICES STAFF AND PERSON SEEKING SUPPORT; AND INCREASE SUPPORT TO UNDERSERVED POPULATIONS BY DEVELOPING RELEVANT RESOURCE GUIDES THAT ADDRESS THE NEEDS OF SPECIFIC UNDERSERVED POPULATIONS (I.E.: PEOPLE OF COLOR, UNINSURED, LGBTQ+, NON-ENGLISH SPEAKING, CAREGIVERS, YOUNG ADULTS). PATIENT EDUCATION PROGRAMMING (VIRTUAL AND IN-PERSON): BARRIERS TO ACCESSING UP-TO-DATE, EXPERT INFORMATION ON LUNG CANCER RESEARCH ADVANCEMENTS AND TREATMENTS ARE EVIDENT BASED ON STIGMA SURROUNDING LUNG CANCER. OUR PATIENT EDUCATION PROGRAMMING AIMS TO INCREASE THE ACCESSIBILITY OF DISEASE AWARENESS AND INFORMATION TO THE LUNG CANCER COMMUNITY BY CREATING EVENTS WHERE LUNG CANCER RESEARCHERS, CLINICIANS, AND OTHER EXPERTS DISCUSS SCIENTIFIC ADVANCEMENT, IMPORTANT UPDATES IN TREATMENTS, AS WELL AS INFORMATION FOR IMPROVING QUALITY OF LIFE WHILE RECEIVING TREATMENT. LCRF ALSO AIMS TO HOST TOPICS THAT WOULD SPECIFICALLY HELP SUPPORT UNDERSERVED POPULATIONS, SUCH AS PEOPLE OF COLOR, THOSE IN LOW SOCIOECONOMIC GROUPS, RURAL DEMOGRAPHICS, AND SPANISH-SPEAKING POPULATIONS, ALL OF WHICH EXPERIENCE A RANGE OF HEALTH DISPARITIES. ATTENDEES, BOTH VIRTUAL AND IN-PERSON, HAVE THE OPPORTUNITY TO LEARN ABOUT LUNG CANCER, TREATMENT OPTIONS AND ADVANCES IN RESEARCH, CLINICAL TRIALS AND AVAILABLE RESOURCES. THEY CAN POSE QUESTIONS TO LUNG CANCER EXPERTS, SHARE THEIR OWN PERSONAL EXPERIENCE, AND ENGAGE WITH THEIR PEERS, FORGING CONNECTIONS AND SUPPORT. THIS PROGRAM ALLOWS PATIENTS AND THEIR FAMILIES TO BECOME MORE INFORMED ABOUT LUNG CANCER AND THEIR OPTIONS FOR NAVIGATING LIFE WITH THEIR DISEASE. THE LEARNING OBJECTIVES OF OUR EDUCATIONAL PROGRAMS ARE: 1. PROVIDE UP-TO-DATE EDUCATION AND INFORMATION ABOUT LUNG CANCER DIAGNOSIS AND TREATMENT, SO OUR AUDIENCE HAS A RELIABLE SOURCE TO TURN TO FOR ACCURATE AND TIMELY INFORMATION; 2. INFORM ABOUT NEW ADVANCEMENTS IN THE FIELD OF LUNG CANCER RESEARCH AND THE TREATMENT LANDSCAPE; 3. PROVIDE OPPORTUNITY FOR DIALOGUE AND A SENSE OF CONNECTION AND COMMUNITY; 4. HIGHLIGHT RESEARCH ADVANCEMENTS, NEWLY DISCOVERED TREATMENT OPTIONS, BEST PRACTICES AND STANDARDS OF CARE FOR PATIENTS UNDERGOING TREATMENT, AND PSYCHOSOCIAL SUPPORT FOR PATIENTS AND THEIR CAREGIVERS; 5. ENSURE AWARENESS OF AND ACCESS TO IMPORTANT LUNG CANCER RESOURCES AND PROGRAMS OFFERED THROUGH LCRF AND ITS PARTNERS. SINCE ITS INCEPTION IN MARCH 2020, WE'VE HAD OVER 7,500 REGISTRANTS FOR OUR #TOGETHERSEPARATELY VIRTUAL EVENTS WITH AN AVERAGE ATTENDANCE RECORD OF OVER 100 INDIVIDUALS PER WEBINAR. MOST OF THE ATTENDEES IN THIS SERIES ARE LUNG CANCER PATIENTS, SURVIVORS, ADVOCATES, CAREGIVERS, AND COMMUNITY PROVIDERS. OUR GOAL IS TO CONTINUE THE SERIES, WHILE FOCUSING ON THE BIGGEST AREAS OF UNMET NEEDS IN THE LUNG CANCER COMMUNITY. ADDITIONALLY, SINCE 2022, WE'VE REINTRODUCED OUR IN-PERSON PROGRAMMING WITH THE LAUNCH OF OUR LCRF TOGETHER IN-PERSO
FORM 990, PART III LINE 4B, PROGRAM SERVICE ACCOMPLISHMENTS, CONTINUED:ADDITIONALLY, SINCE 2022, WE'VE REINTRODUCED OUR IN-PERSON PROGRAMMING WITH THE LAUNCH OF OUR LCRF TOGETHER IN-PERSON EDUCATIONAL PROGRAM SERIES. WE HOSTED OUR FIRST LCRF TOGETHER PROGRAM IN CHICAGO, ILLINOIS ON JUNE 28, 2022. THIS EVENT HAD OVER 50 PEOPLE IN ATTENDANCE, INCLUDING PATIENTS AND CAREGIVERS, THOSE WHO HAVE LOST A LOVED ONE, AS WELL AS HEALTHCARE PROFESSIONALS AND INDUSTRY SPONSORS.
FORM 990, PART VI, SECTION A, LINE 2MARY ANN TIGHE AND AARON M. TIGHE - FAMILY RELATIONSHIP MARY ANN TIGHE AND RAYMOND E. CHALME - BUSINESS RELATIONSHIP
FORM 990, PART VI, SECTION B, LINE 11BA DRAFT OF THE RETURN IS REVIEWED FIRST BY THE EXECUTIVE COMMITTEE AND THEN BY THE BOARD OF DIRECTORS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CTHE BOARD REVIEWS THE CONFLICT OF INTEREST POLICY ANNUALLY, AND ASKS ALL BOARD MEMBERS AND EMPLOYEES TO DISCLOSE ANY CONFLICTS OR POTENTIAL CONFLICTS. IN ADDITION, ALL CONTRACTS ARE REVIEWED FOR KNOWN OR POTENTIAL CONFLICTS BY THE EXECUTIVE DIRECTOR, SR. DIRECTOR FINANCE & ADMINISTRATION AND THE EXECUTIVE COMMITTEE ON AN ON-GOING BASIS.
FORM 990, PART VI, SECTION B, LINE 15THE EXECUTIVE COMMITTEE OF THE BOARD LOOKS AT COMPENSATION SURVEYS AND ALSO COMPARES SALARIES IN SIMILAR ORGANIZATIONS TO DETERMINE THE REASONABLENESS OF SALARIES FOR KEY EMPLOYEES. THE EXECUTIVE COMMITTEE ALSO CONSIDERS OTHER PERFORMANCE-BASED CRITERIA WHICH INCLUDES A WRITTEN PERFORMANCE APPRAISAL OF THE EXECUTIVE DIRECTOR.
FORM 990, PART VI, SECTION C, LINE 19FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. ALL OTHER DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON RECEIPT OF A WRITTEN REQUEST.
FORM 990, PART XI, LINE 9:RETURNED GRANT FUNDS 87,950.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.